Number of Shares
46,300.00
Current Holdings Value*
$724,130.00
% of Portfolio
4.62%
Total Estimate Gain
$167,212.00
% of Total Estimate Gain
35.62%

Lion Point Capital, LP's Arcutis Biotherapeutics Inc Holding Summary

As of 2025-03-31, Lion Point Capital, LP held 46,300.00 shares of Arcutis Biotherapeutics Inc(ARQT), totaling $724,130.00. This investment constitutes 4.62% of their stock portfolio, and Lion Point Capital, LP now holds 0.04% of the outstanding Arcutis Biotherapeutics Inc(ARQT) stock.

The initial trade took place in 2024Q3. And since then Lion Point Capital, LP has made 2 purchases of ARQT, at an average price of $10.14, for a total of 46,300.00 shares. Based on historical transaction data and ARQT's current price of $13.75, Lion Point Capital, LP's estimated gain on his ARQT holdings is $167,212.00, reflecting a 35.62% gain to date.

Lion Point Capital, LP ARQT ($13.75) Holding Chart

Lion Point Capital, LP ARQT ($13.75) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1